𝑰𝒕'𝒔 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑻𝒓𝒊𝒂𝒍𝒔 𝑫𝒂𝒚! And what better way to celebrate than to expand trial access to patients and providers. We're excited to announce our Rapid Feasibility Tool, a 100% HIPAA-compliant, easy-to-use tool to understand and showcase your trial site's most valuable asset: your patient population. --- ⛵ To celebrate today's special occasion, we're giving away 3 months of feasibilities — unlimited EMRs, unlimited feasibility reports — if you sign up this week. --- These days, there are countless clinical trial sites with the facilities, equipment, and personnel required to operate most trials. But only 𝙮𝙤𝙪𝙧 site has 𝙮𝙤𝙪𝙧 patient population. We'll help you prove it. Connect the feasibility tool to 1, 10, or 100 EMRs (with aggressive bulk discounts above 3 EMRs) and craft your strongest pitch to sponsors for the trials you really want. Check out the video below! Some FAQs and the link to join the waitlist is in the comments. #clinicaltrialsday #clinicaltrials
SelectIQ’s Post
More Relevant Posts
-
Outsourcing in Clinical Trial DACH 2024 It was great to be part of the fireside chat at the #OCTDACH2024 talking about „Enhancing site accessibility and collaboration in clinical trials to reduce the burden on sites“. Thanks Eric Hajjar for this lively discussion and navigating me through this topic. Never stop the investments in building long-term partnerships with all the stakeholders on each level of the clinical trial journey! Personal communication is key for the success of the clinical trials. #clinicaltrials, #clinicaloperations,
To view or add a comment, sign in
-
Quick Question for my Clinical Operation's connections. Does this sound right? Can you spend up to an additional $60,000 to identify and activate new sites during an ongoing clinical trial? Is this per site? #clinicaltrials #clinicaloperations #citeline
To view or add a comment, sign in
-
Are you missing out on this simple way to boost your patients’ well-being? You’d be surprised: many people are willing to participate in clinical trials, but most of them have never been asked. 👉 Why? According to the Tufts Center for the Study of Drug Development, even though 91% of physicians are comfortable discussing clinical trials: - 54% don’t have access to trial info. - 48% don’t know where to refer patients. - 33% lack the time to learn about available trials. So, why should we start this conversation? Clinical trials can: 1. Give patients access to cutting-edge treatments they won’t find elsewhere. 2. Offer hope and potential benefits beyond standard care. 3. Help advance medical understanding, which could benefit countless future patients. And here’s a tip: If you’re looking for trial information, clinicaltrials.gov is a great place to start. It’s a comprehensive resource for finding current clinical trials that might be right for your patients. 👉 Let’s not wait for the perfect moment. Let’s make the moment perfect. It’s time to bridge this gap. 🧩 Start the conversation with your patients today! If you found this helpful, please consider resharing ♻️ and spreading awareness. Together, we can make a difference.
To view or add a comment, sign in
-
🙌 Welcome to #SCOPESummit clinical trial innovators! 🙌 Look for the famous SEQSTER Green 👟to get a DEMO of our 1-Click Records™ to accelerate your #ClinicalTrials. #DigitalHealth #PatientCentricity #HealthData
To view or add a comment, sign in
-
#scopesummit was great. It was wonderful to see so many familiar faces and meet many new. It was my first scope with Verified Clinical Trials and it’s safe to say it was a massive success. Some sponsors still don’t believe cross-sponsor duplicate participants is an issue, which is a bit concerning, but the majority agree that there is an issue and using VCT to prevent cross-sponsor duplicate research participants is no longer a “nice to have”, but a best practice. If you’re planning a clinical trial, let’s collaborate to enhance patient safety and data quality because there is a high likelihood that ineligible participants are enrolling in your studies if you don’t have a solution in place to prevent duplicate participants at screening. Ps - if you’re a patient recruitment company, let’s collaborate to give you a competitive advantage. Based on the number of recruitment companies at scope, ensuring the participants you’re referring to a clinical trial are not already involved in another clinical trial will be a huge differentiator.
To view or add a comment, sign in
-
As the competition in the clinical trial industry continues to grow, traditional sites are facing the challenge of standing out to sponsors and CROs in order to secure more studies. In this blog post, we explore essential strategies for traditional sites to thrive in this competitive landscape. 💡 Key Highlights: ✅ A strong patient registry is crucial for any clinical trial site. Find out how maintaining one can make your site the top choice for new studies. ✅ Learn about the significance of clean, trackable data and how it enhances your site's attractiveness to sponsors and CROs by establishing credibility and reliability. ✅ Discover how standardized processes can reduce errors, manage costs, and improve the overall quality of your site's operations. Attracting more studies relies on enhancing consistency, quality, and reputation. Explore actionable insights that can differentiate your site here: 🔗 https://lnkd.in/eERNVjfk #ClinicalTrials #PatientEnrollment #CleanData #StreamlinedProcesses #ClinicalResearch #Innovation
To view or add a comment, sign in
-
2 weeks to go! Have you secured your spot for this insightful webinar? Register now to hear more about 'understanding the patient journey'
⏳ 5th September - Your chance to listen live to experts from Greenphire Timothy Dorsey, Steven Geffon, Dave Hine + Jaleeysa King https://lnkd.in/exixXBHA Recruiting and retaining patients for clinical trials can be challenging, dropout rates are around 30%. Sponsors are increasing payment and offering travel services to improve access, engagement, and diversity. How much should be budgeted for these critical solutions? Reserve your spot now to get the chance to learn more about: ☀ The burden associated with participating in a clinical trial ☀The best mix of clinical trial support ☀The tools to forecast and budget trial costs across phases, therapeutic areas and country ☀The ability to negotiate contracts with confidence
Understanding the Patient Journey
https://www.arena-international.com
To view or add a comment, sign in
-
⏳ 5th September - Your chance to listen live to experts from Greenphire Timothy Dorsey, Steven Geffon, Dave Hine + Jaleeysa King https://lnkd.in/exixXBHA Recruiting and retaining patients for clinical trials can be challenging, dropout rates are around 30%. Sponsors are increasing payment and offering travel services to improve access, engagement, and diversity. How much should be budgeted for these critical solutions? Reserve your spot now to get the chance to learn more about: ☀ The burden associated with participating in a clinical trial ☀The best mix of clinical trial support ☀The tools to forecast and budget trial costs across phases, therapeutic areas and country ☀The ability to negotiate contracts with confidence
Understanding the Patient Journey
https://www.arena-international.com
To view or add a comment, sign in
-
Having issues with clinical trial recruitment? Help your clinical and leadership teams make better, data driven clinical trial decisions. reverbaPULSE™ delivers patient satisfaction data in real time through a sponsor portal to help your teams understand how to improve current or future trials. Get in-trial insights with reverbaPULSE™ to optimize clinical trial recruitment, retention, and future trial design – find out how https://bit.ly/42s2Oed #clinicaltrialrecruitment #datadriventrialdecisions #patientsatisfaction
To view or add a comment, sign in
349 followers